GMO Pepabo, Inc. provided consolidated earnings guidance for the year ending December 31, 2024. For the year, the company expects net sales of ¥10,963 million, operating profit of ¥700 million, profit attributable to owners of parent ¥421 million and basic earnings per share of ¥79.95.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,341 JPY | +0.07% | +0.98% | +14.71% |
Feb. 13 | GMO Pepabo, Inc. Provides Dividend Guidance for the Year Ending December 31, 2024 | CI |
Feb. 13 | GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.71% | 46.01M | |
+23.71% | 429B | |
+16.08% | 244B | |
+11.37% | 143B | |
+16.30% | 101B | |
+21.14% | 86.69B | |
+56.55% | 58.56B | |
+15.57% | 46.74B | |
+15.33% | 35.13B | |
+9.34% | 27.67B |
- Stock Market
- Equities
- 3633 Stock
- News GMO Pepabo, Inc.
- GMO Pepabo, Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024